OBJECTIVE	We previously reported that nifedipine retard showed comparable efficacy to angiotensin-converting enzyme ( ACE ) inhibitors for the prevention of cardiac events in hypertensive patients with coronary artery disease during the Japan Multicenter Investigation for Cardiovascular Diseases B study .\